Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Tamoxifen citrate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tamoxifen 20mg tablets
0803041S0AAABAB
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | 118,218 |
|
Tamoxifen 10mg tablets
0803041S0AAAAAA
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | 4,896 |
|
Tamoxifen 10mg/5ml oral solution sugar free
0803041S0AAAJAJ
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | 795 |
|
Tamoxifen 40mg tablets
0803041S0AAACAC
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | 80 |
|
Tamoxifen 10mg/5ml oral liquid
0803041S0AAAHAH
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamoxifen 20mg/5ml oral liquid
0803041S0AAAGAG
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamoxifen 40mg/5ml oral liquid
0803041S0AAAIAI
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.